The Gb3-cSrc complex within sphingolipid-enriched microdomains in cancer cell membranes can upregulate m6A modifications in the p53 pre-mRNA point mutation codon 273 by increasing the expression of methyltransferase-like 3, producing DOX resistance with increasing ceramide glycosylation [87]. The gene discussed is TP53; the disease is cancer.